Sentence examples for pediatric markets from inspiring English sources
Vaccine manufacturers, for example, receive 6 months of exclusivity in pediatric markets in high-income countries, 33 and no mechanism exists to deal with eventual price increases.
Pediatric markets become fragmented into niches with little demand as manufacturers develop more acceptable, age-appropriate pediatric products, and adopting improved formulations may present logistical challenges in some countries.
Ensuring a long-term supply of quality, well-adapted ARVs for children requires ongoing monitoring and improved understanding of global pediatric markets, including country-based research to explain and address low uptake of new, improved formulations.
But pharmaceutical executives did not have much interest in the tiny pediatric market.
The pediatric market is far smaller than the market for adults, making it difficult for companies to recoup research and development expenses for smaller devices.
Miralax's manufacturer, Merck, has no incentive to seek F.D.A. approval for children; the company already sells tons of this drug to the pediatric market.
Augmentin XR, a patented new version of the antibiotic, has 15percentt of prescriptions for adult patents, while Augmentin ES, another new form, has about 50percentt of the pediatric market, the company said.
In the context of our scenario, the pediatric market demand analysis lists expert personnel deficiency in five sub-specialization for the next coming seven years (2016-2021) thareAllergy/Immunlogynlogy, Anesthesiology, Cardiology, Cardiothoracic Surgery, and Critical Care (Ministries 2015).
In addition to research conducted under the pediatric exclusivity program, there has been an increased general interest of pharmaceutical companies in the pediatric market.
Numerous products are needed in varying strengths to accommodate changing doses as children grow, which fragments the pediatric market for a given ARV into even smaller niches.
This situation, despite the efforts of the Food and Drug Administration and the US Congress, is not likely to improve substantially due to the economic reality of the pediatric market.
